Fumaric Acid

Fumaric Acid

SCHEMBL1793181

Cc1cccc(-c2ccc(N3CC4CNCC43)cn2)c1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 17/20 0.47
CHRNA4 P43681 17/20 0.47
CHRNB4 P30926 16/20 0.47
CHRNA3 P32297 16/20 0.47
CHRNA7 P36544 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL1793186 1.00 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL927618 0.91 CHRNB2 (0.55) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL1793257 0.91 CHRNB2 (0.55) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL1792587 0.80 CHRNB2 (0.69) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL927548 0.80 CHRNB2 (0.69) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
Fumaric Acid SCHEMBL650703 0.77 CHRNB2 (0.79) CHRNB2CHRNA4CHRNB4CHRNA3
Fumaric Acid SCHEMBL651750 0.77 CHRNB2 (0.79) CHRNB2CHRNA4CHRNB4CHRNA3
Fumaric Acid SCHEMBL650704 0.77 CHRNB2 (0.79) CHRNB2CHRNA4CHRNB4CHRNA3
Fumaric Acid SCHEMBL651856 0.77 CHRNB2 (0.79) CHRNB2CHRNA4CHRNB4CHRNA3
Fumaric Acid SCHEMBL650701 0.77 CHRNB2 (0.79) CHRNB2CHRNA4CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2316836-A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors Abbott Laboratories (US) 2011-05-04 EP disclosed